Dublin, Nov. 22, 2024 (GLOBE NEWSWIRE) -- The "Diabetes Injection Pens - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market for Diabetes ...
Zydus Lifesciences has launched Semaglutide Injection under the brand names SEMAGLYN, MASHEMA and ALTERME, upon patent expiry in India. The Drug Controller General of India (DCGI) had earlier provided ...
Rising Chronic Disease Burden, Biosimilar Insulin Adoption, and Smart Connected Pen Technologies Drive Sustained Market Expansion.Austin, United States, March 12, 2026 (GLOBE NEWSWIRE) -- As per SNS ...
A real-world study conducted across 9 European countries found that bolus injection frequency and engagement with a smart pen to administer insulin were associated with improved glycemic control among ...
The global injection pen market is set to witness a growth rate of 7% in the next 5 years. Rising prevalence of chronic diseases, patient convenience and ease of use, technological advancements, ...
For people who require insulin therapy, staying on top of multiple daily injections and getting the dosages right can be an overwhelming task. Insulin pens can make diabetes management easier, and ...
Owen Mumford has released a new injection pen training video. Developed in collaboration with consultant pharmacists and nursing professionals, the video addresses critical steps when clinically ...
The Diabetes Injection Pens Market is expected to witness a growth rate of ~7% by 2028. The key factors driving the market are the rising prevalence of diabetes, the growing preference for pens over ...
Anavip contains venom-specific F(ab’)2 fragments of immunoglobulin G that bind and neutralize venom toxins. Novo Nordisk announced the availability of Ozempic (semaglutide) injection 1mg as a single ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results